Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 12.90
-0.08 (-0.62%)
Aug 4, 2026, 3:00 PM CST
SHA:688526 Market Cap
SHA:688526 has a market cap or net worth of 5.98 billion as of August 4, 2026. Its market cap has decreased by -23.35% in one year.
Market Cap
5.98B
Enterprise Value
3.39B
Revenue
932.09M
Ranking
n/a
PE Ratio
15.36
Stock Price
12.90
ChartMarket Cap Chart
Since September 22, 2020, SHA:688526's market cap has decreased from 14.68B to 5.98B, a decrease of -59.25%. That is a compound annual growth rate of -14.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 5.98B | -15.47% |
| Dec 31, 2025 | 7.08B | 6.68% |
| Dec 31, 2024 | 6.64B | -30.15% |
| Dec 29, 2023 | 9.50B | -9.03% |
| Dec 30, 2022 | 10.44B | -18.45% |
| Dec 31, 2021 | 12.81B | -33.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovita Biological Technology | 7.71B |
| Daan Gene | 7.65B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 7.59B |
| Bio-Thera Solutions | 7.08B |
| Shanghai OPM Biosciences | 6.80B |
| Zhejiang Ausun Pharmaceutical | 6.12B |
| Chengdu Kanghua Biological Products | 6.01B |
| Jiangsu Aidea Pharmaceutical Group | 5.82B |